Literature DB >> 15774241

Using tree analysis pattern and SELDI-TOF-MS to discriminate transitional cell carcinoma of the bladder cancer from noncancer patients.

Weiwei Liu1, Ming Guan, Denglong Wu, Yuanfang Zhang, Zhong Wu, Ming Xu, Yuan Lu.   

Abstract

OBJECTIVE: To determine whether SELDI protein profiling of urine coupled with a tree analysis pattern could differentiate TCC from noncancer patients.
METHODS: The ProteinChip Arrays were performed on a ProteinChip PBS II reader of the ProteinChip Biomarker System. The study was divided into two phases: a preliminary phase with construction of tree analysis pattern, and a testing phase with test urine samples. Generation of the tree analysis pattern was performed by a training data set consisting of 104 samples. The validity of the tree analysis pattern was then challenged with a test set of 68 samples.
RESULTS: Average of 187 mass peaks was detected in the urine samples, and five of these peaks were used to construct the tree analysis pattern. The classification pattern correctly predicted 91.67-94.64% of the samples for both of the two groups in the training set, for an overall correct classification of about 93%. The pattern correctly predicted 72.0% (49 of 68) of the test samples, with 71.4% (25 of 35) of the TCC samples, 72.7% (24 of 33) of the noncancer samples.
CONCLUSIONS: The high sensitivity and specificity obtained by the urine protein profiling approach demonstrate that SELDI-TOF-MS combined with a tree analysis pattern can both facilitate discriminate TCC bladder cancer with noncancer and provide an innovative clinical diagnostic platform improve the detection of TCC bladder cancer patients.

Entities:  

Mesh:

Year:  2004        PMID: 15774241     DOI: 10.1016/j.eururo.2004.10.006

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  13 in total

Review 1.  [Identification of biomarkers and therapeutic targets for renal cell cancer using ProteinChip technology].

Authors:  K Junker; F von Eggeling; J Müller; T Steiner; J Schubert
Journal:  Urologe A       Date:  2006-03       Impact factor: 0.639

2.  High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine.

Authors:  Harald Mischak; Bruce A Julian; Jan Novak
Journal:  Proteomics Clin Appl       Date:  2007-07-10       Impact factor: 3.494

Review 3.  Better cancer biomarker discovery through better study design.

Authors:  Andrew Rundle; Habibul Ahsan; Paolo Vineis
Journal:  Eur J Clin Invest       Date:  2012-09-23       Impact factor: 4.686

4.  Proteiomic patterns for endometrial cancer using SELDI-TOF-MS.

Authors:  Li-rong Zhu; Wen-ying Zhang; Li Yu; Yan-hua Zheng; Jun Hu; Qin-ping Liao
Journal:  J Zhejiang Univ Sci B       Date:  2008-04       Impact factor: 3.066

5.  Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer.

Authors:  Jie Du; Shuanying Yang; Xiuli Lin; Lina Bu; Yandong Nan; Shufen Huo; Wenli Shang
Journal:  Diagn Pathol       Date:  2010-09-20       Impact factor: 2.644

Review 6.  High throughput molecular diagnostics in bladder cancer - on the brink of clinical utility.

Authors:  Karsten Zieger
Journal:  Mol Oncol       Date:  2007-12-08       Impact factor: 6.603

7.  Examining the significance of fingerprint-based classifiers.

Authors:  Brian T Luke; Jack R Collins
Journal:  BMC Bioinformatics       Date:  2008-12-17       Impact factor: 3.169

8.  Discovery and validation of urinary biomarkers for prostate cancer.

Authors:  Dan Theodorescu; Eric Schiffer; Hartwig W Bauer; Friedrich Douwes; Frank Eichhorn; Reinhard Polley; Thomas Schmidt; Wolfgang Schöfer; Petra Zürbig; David M Good; Joshua J Coon; Harald Mischak
Journal:  Proteomics Clin Appl       Date:  2008-03-07       Impact factor: 3.494

Review 9.  Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform.

Authors:  Eric Schiffer; Harald Mischak; Dan Theodorescu; Antonia Vlahou
Journal:  World J Urol       Date:  2008-01-04       Impact factor: 4.226

10.  Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry: serum protein profiling in seminoma patients.

Authors:  Romy Strenziok; Stefan Hinz; Christian Wolf; Tim Conrad; Hans Krause; Kurt Miller; Mark Schrader
Journal:  World J Urol       Date:  2009-06-16       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.